Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells (Q39344613)

11 September 2017

title

Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells (English)

1 reference

11 September 2017

0 references

1 reference

Leyla Kavandi

1 reference

11 September 2017

Michael A Collier

series ordinal

1 reference

11 September 2017

Huyen Nguyen

series ordinal

1 reference

11 September 2017

Viqar Syed

series ordinal

1 reference

11 September 2017

publication date

1 October 2012

1 reference

Journal of Cellular Biochemistry

11 September 2017

published in

1 reference

11 September 2017

volume

113

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

3143-3152

1 reference

IKKalpha and IKKbeta each function to regulate NF-kappaB activation in the TNF-induced/canonical pathway

11 September 2017

cites work

1 reference

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

Pathways connecting inflammation and cancer

21 January 2018

1 reference

Chemokines in cancer related inflammation

21 January 2018

1 reference

Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

21 January 2018

1 reference

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

21 January 2018

1 reference

Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth.

21 January 2018

1 reference

Transcription factors as targets for cancer therapy

21 January 2018

1 reference

Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.

21 January 2018

1 reference

Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors

21 January 2018

1 reference

Progestin suppresses matrix metalloproteinase production in endometrial cancer

21 January 2018

1 reference

Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses

21 January 2018

1 reference

Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat

21 January 2018

1 reference

Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer

21 January 2018

1 reference

Successful immortalization of endometrial glandular cells with normal structural and functional characteristics

21 January 2018

1 reference

21 January 2018

1 reference

Molecular Pathways Linking Inflammation and Cancer

21 January 2018

1 reference

Cancer-related inflammation

21 January 2018

1 reference

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

21 January 2018

1 reference

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species

21 January 2018

1 reference

Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.

21 January 2018

1 reference

Good cop, bad cop: the different faces of NF-kappaB

21 January 2018

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium

21 January 2018

1 reference

Lithocholic acid down-regulation of NF-kappaB activity through vitamin D receptor in colonic cancer cells

21 January 2018

1 reference

Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL

21 January 2018

1 reference

Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation

21 January 2018

1 reference

1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.

21 January 2018

1 reference

Nuclear factor-kappaB in development, prevention, and therapy of cancer

21 January 2018

1 reference

The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃

21 January 2018

1 reference

Inflammatory events in endometrial adenocarcinoma.

21 January 2018

1 reference

Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1 beta via reduced p38 mitogen-activated protein kinase phosphorylation.

21 January 2018

1 reference

Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24191

1 reference

11 September 2017

1 reference